182 related articles for article (PubMed ID: 11274927)
61. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
[TBL] [Abstract][Full Text] [Related]
62. Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode.
Bligt-Lindén E; Pihlavisto M; Szatmári I; Otwinowski Z; Smith DJ; Lázár L; Fülöp F; Salminen TA
J Med Chem; 2013 Dec; 56(24):9837-48. PubMed ID: 24304424
[TBL] [Abstract][Full Text] [Related]
63. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes.
Salmi M; Tohka S; Berg EL; Butcher EC; Jalkanen S
J Exp Med; 1997 Aug; 186(4):589-600. PubMed ID: 9254657
[TBL] [Abstract][Full Text] [Related]
64. Targeting vascular adhesion protein-1 to treat autoimmune and inflammatory diseases.
Smith DJ; Vainio PJ
Ann N Y Acad Sci; 2007 Sep; 1110():382-8. PubMed ID: 17911453
[TBL] [Abstract][Full Text] [Related]
65. Reaction of vascular adhesion protein-1 (VAP-1) with primary amines: mechanistic insights from isotope effects and quantitative structure-activity relationships.
Heuts DP; Gummadova JO; Pang J; Rigby SE; Scrutton NS
J Biol Chem; 2011 Aug; 286(34):29584-93. PubMed ID: 21737458
[TBL] [Abstract][Full Text] [Related]
66. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans.
Salmi M; Jalkanen S
Science; 1992 Sep; 257(5075):1407-9. PubMed ID: 1529341
[TBL] [Abstract][Full Text] [Related]
67. Localization of vascular adhesion protein-1 (VAP-1) in the human eye.
Almulki L; Noda K; Nakao S; Hisatomi T; Thomas KL; Hafezi-Moghadam A
Exp Eye Res; 2010 Jan; 90(1):26-32. PubMed ID: 19761765
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis.
Noda K; Miyahara S; Nakazawa T; Almulki L; Nakao S; Hisatomi T; She H; Thomas KL; Garland RC; Miller JW; Gragoudas ES; Kawai Y; Mashima Y; Hafezi-Moghadam A
FASEB J; 2008 Apr; 22(4):1094-103. PubMed ID: 18032635
[TBL] [Abstract][Full Text] [Related]
69. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.
Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA
PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774
[TBL] [Abstract][Full Text] [Related]
70. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme.
Bonaiuto E; Lunelli M; Scarpa M; Vettor R; Milan G; Di Paolo ML
Biochimie; 2010 Jul; 92(7):858-68. PubMed ID: 20298739
[TBL] [Abstract][Full Text] [Related]
71. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
72. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
73. Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Carpéné C; Bizou M; Tréguer K; Hasnaoui M; Grès S
J Physiol Biochem; 2015 Sep; 71(3):487-96. PubMed ID: 25572340
[TBL] [Abstract][Full Text] [Related]
74. SSAO/VAP-1 protein expression during mouse embryonic development.
Valente T; Solé M; Unzeta M
Dev Dyn; 2008 Sep; 237(9):2585-93. PubMed ID: 18729210
[TBL] [Abstract][Full Text] [Related]
75. Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3.
Elovaara H; Kidron H; Parkash V; Nymalm Y; Bligt E; Ollikka P; Smith DJ; Pihlavisto M; Salmi M; Jalkanen S; Salminen TA
Biochemistry; 2011 Jun; 50(24):5507-20. PubMed ID: 21585208
[TBL] [Abstract][Full Text] [Related]
76. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis.
Ujula T; Salomäki S; Virsu P; Lankinen P; Mäkinen TJ; Autio A; Yegutkin GG; Knuuti J; Jalkanen S; Roivainen A
Nucl Med Biol; 2009 Aug; 36(6):631-41. PubMed ID: 19647169
[TBL] [Abstract][Full Text] [Related]
77. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule.
Smith DJ; Salmi M; Bono P; Hellman J; Leu T; Jalkanen S
J Exp Med; 1998 Jul; 188(1):17-27. PubMed ID: 9653080
[TBL] [Abstract][Full Text] [Related]
78. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice.
Wang SH; Yu TY; Tsai FC; Weston CJ; Lin MS; Hung CS; Kao HL; Li YI; Solé M; Unzeta M; Chen YL; Chuang LM; Li HY
Transl Res; 2018 Jul; 197():12-31. PubMed ID: 29653075
[TBL] [Abstract][Full Text] [Related]
79. Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line).
Solé M; Hernandez M; Boada M; Unzeta M
J Neural Transm (Vienna); 2007; 114(6):763-7. PubMed ID: 17393062
[TBL] [Abstract][Full Text] [Related]
80. Vascular adhesion protein-1 as a potential therapeutic target in liver disease.
Lalor PF; Tuncer C; Weston C; Martin-Santos A; Smith DJ; Adams DH
Ann N Y Acad Sci; 2007 Sep; 1110():485-96. PubMed ID: 17911464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
